Escalating concerns about the H7N9 influenza strain that has surfaced in China have prompted scientists to use new technology to create a viral seed strain, potentially shortening the development time for a vaccine. The approach, developed after the 2009 H1N1 pandemic, uses the genetic code of the virus, instead of a sample of the virus itself, to create synthetic DNA and manufacture the virus then used in vaccine development. The time saved could be critical, said Robin Robinson, director of the Biomedical Advanced Research and Development Authority.

Full Story:

Related Summaries